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ABSTRACT
Background: Occult cervical lymph node metastasis is a relatively rare oncologic disease presenting as a 
neck lump without an obvious mucosal lesion. Most cases arise from the upper aerodigestive tract and 
affect all ages. It is often a diagnostic dilemma when there is no facility to carry out a thorough evaluation.
Methods: A prospective study of all patients with neck lump with unknown primary tumor site evaluated 
within the periods, January 2010 to December 2012 at the ENT/Head and Neck Department of University 
College Hospital, Ibadan. The patients went through clinical, radiological and endoscopic assessments. 
Fine Needle Aspirate and Cytology (FNAC) of neck node and random pan-endoscopic specimens obtained 
were cytological and histological analysed.
Results: The prevalence of cervical nodal metastasis with unknown primary site was 9.7%. We found no 
gender predilection in the study. Majority of the patients with occult cervical node metastases were in the 
third decade of life. The histological yield of pan-endoscopy biopsy specimen was 72%. Undifferentiated 
nasopharyngeal squamous (39%) cell carcinoma was the commonest diagnosis following random biopsy 
during pan-endoscopy.
Conclusion: Despite limitations arising from lack of FDG PET, the yield from pan-endoscopy biopsy 
specimen was appreciable.  Inadequate immunohistological stains and lack of FDG PET scan may have 
diminished the histological yield of the blind pan-endoscopy biopsy specimens.
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INTRODUCTION
The definition of metastatic cancer of unknown 
primary is a biopsy-confirmed malignancy for 
which the site of origin at routine workup is not 
1identified . Cervical lymph node metastasis from 
unknown primary site is a relatively rare event. It 
presents as a neck lump without an obvious 
mucosal lesion. The majority of these tumors arise 
from upper aerodigestive tract. Studies of head and 
 2,3,4,5
neck squamous cell carcinoma (HNSCC)  
estimate that the incidence of cervical lymph node 
metastasis with no obvious primary site ranges 
from 3% to 9%, with squamous cell carcinoma 
(SCC) constituting about 75% of the tumor.
Due to the protean possible causes of neck masses, 
the assessment of the patients has to be fast-tracked 
and this must follow a strict protocol for timely and 
appropriate diagnosis. The clinical evaluation of 
these patients includes a complete medical history 
and physical examination, chest radiography, 
indirect or flexible fiber-optic endoscopy. 
Computed tomography may be useful in evaluation 
of the chest, neck and skull base. Pan endoscopy 
often entai ls  performing laryngoscopy,  
bronchoscopy, esophagoscopy, fiber-optic 
nasopharyngoscopy and biopsy of all suspicious 
lesions or areas (tongue base, nasopharynx, tonsils, 
piriform sinus and bronchus) needed to be done for 
the evaluation of the upper aerodigestive tract and 
lungs. The recommendation is that in cases of 
negative biopsy results from the random or blind 
biopsies, any identified solitary enlarged lymph 
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node with the capsule intact should be biopsied. 
Pre-operative FNAC of the cervical mass is also 
2, 6helpful in cases of diagnostic dilemma .
The most frequent histopathologic diagnosis is 
SCC accounting for 65% to 76% of cervical lymph 
node metastasis from unknown primary site, 
followed by undifferentiated carcinoma (14%), 
adenocarcinoma (13%) and nasopharyngeal-type 
 7carcinoma (8%) . Approximately one third of the 
metastasis from unknown primary site are found in 
8
lymph node  and over 90% of the neck metastasis 
9comprises SCC , whereas undifferentiated 
carcinoma, adenocarcinoma  and other 
malignancies (thyroid carcinoma, malignant 
melanoma) are less common in western world. 
Undifferentiated carcinomas are commoner in 
countries with high prevalence of nasopharyngeal 
carcinoma.
There are two theories postulated to explain why 
the primary neoplasms may be occult in nature. The 
first theory suggests that the occult primary may be 
due to complete involution of the primary lesion or 
due to a genetic influence, which favors metastatic 
10growth over primary tumor growth . 
Neck nodal metastases present mostly as firm solid 
masses but a distinct subset of lymph nodes with 
metastases may present as cystic masses and these 
frequently relate to thyroid carcinoma followed by 
11 12SCC and melanoma . Goldenberg et al  observed 
that certain SCCs of the tonsils are more likely to 
produce cystic metastasis. Nodal metastasis can be 
found in every neck level, while metastasis from 
unknown primary site are  most frequently found in 
13,14,15,16
level  II . Neck nodes from unknown primary 
15,17
site present bilaterally in 10% of cases . In 
general , nodes in levels I to III are presumably due 
to primary SCC located in the mucosa of the 
18,19aerodigestive tract , whereas nodes in levels IV 
and Vb more often arise from proximal esophageal 
20,21and thyroid carcinoma . Lymph nodes in level IIb 
and Vb are more typical of nasopharyngeal 
11carcinoma .
The purpose of this study is to determine the 
prevalence of cervical nodal metastasis with 
unknown primary tumor site in a tertiary health 
facility in West African sub-region and to find out 
the histological profile and yield of cervical nodal 
and/or random biopsies from pan-endoscopy.
PATIENTS AND METHOD
We prospectively collated data of patients with 
cervical lymph nodes with unknown primary sites 
who had FNAC, Computerized tomographic scan, 
pan-endoscopy and random surgical biopsies of 
upper aerodigestive tract and/or solitary cervical 
lymph node excision biopsy over a three years 
period from January 2010 to December 2013 at 
University College Hospital, Ibadan, Nigeria.  Only 
patients with unknown primary tumor after clinical, 
computerized tomography scan of neck/thorax and 
endoscopic evaluations enrolled for the study.
RESULTS
One hundred and eighty five patients with head and 
neck cancers admitted for evaluation and treatment 
by Otorhinolaryngology Department and 
Oral/Maxillofacial Department at the University 
College Hospital within the study period, January 
2010 to December 2012. Eighteen patients out of 
the 185 patients had cervical lymph node metastasis 
with unknown primary site. The prevalence of 
cervical nodal metastasis with unknown primary 
site in this study is 9.7%. These patients with 
positive nodal metastasis had a male to female ratio 
of 0.8: 1. The mean age of the study population was 
39.6 years with majority (22.2%) of the patients in 
the third decade of life. Ten (56%) patients had right 
sided neck swelling, 4(22%) patients had bilateral 
neck swellings and 4(22%) patients had left sided 
neck swelling. Three of the patients with bilateral 
n e c k  s w e l l i n g s  h a d  n a s o p h a r y n g e a l  
undifferentiated squamous cell cancer and the 
f o u r t h  p a t i e n t  h a d  n a s o p h a r y n g e a l  
neurofibrosarcoma. Cervical nodal level 
involvement of levels IIB, III and IV were 
consistent with nasopharyngeal cancer. The FNAC 
was only positive minimal invasive diagnostic 
investigation for cervical nodal metastatic thyroid 
malignancy. Pan endoscopy was often indicated 
when FNAC was reported to be suspicious of 
malignancy. The histologic yield of pan endoscopic 
biopsy was 72%. Two (15%) patients had well 
differentiated SCC of nasopharynx, 1(8%) patient 
had moderately differentiated SCC of nasopharynx, 
5(39%) patients had undifferentiated SCC of 
nasopharynx, 2 (15%) patients had low grade NHL 
of nasopharynx, 2 (15%) patients had high grade 
large cell NHL of the tonsils and 1(8%) patient had 
moderately differentiated SCC of the hypo pharynx. 
Cervical nodal biopsy histology of NHL correlated 
positively with blind tissue histology obtained from 
pan-endoscopy specimen. Nine (50%) of the 
patients had unknown primary tumor site in the 
nasopharynx and this was found to be the 
commonest anatomic site for unknown primary site 
in the study population. The results of the study are 
summarized in table 1, figures 1, 2 and 3. 
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Table 1: Showing Summary of Results in the study Population with Cervical Nodal Metastasis and 
unknown Primary Tumour Site
FIGURE 1- Showing Age Distribution by Decades in the study population
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FIGURE 2: Showing Macroscopic findings at 
Panendoscopy
FIGURE 3: Showing Histologic Profile of 
Panendoscopic Biopsies in the study population 
DISCUSSION
Metastatic cancer with unknown primary tumor 
site is said to be the 7th most common 
22
malignancy . The prevalence of cervical nodal 
metastasis with unknown primary site in our study 
population was 9.7%. The prevalence in our study 
agrees with earlier report in literature by de Braud 
2
and Al-Sarraf who found a prevalence of 3%-9% .
23, 24
While works by some authors , revealed a male 
preponderance for cervical nodal metastasis with 
unknown primary site in their series, we did not 
find a significant gender predilection.  Neck lymph 
nodes with metastasis of unknown primary site 
were more common in the 3rd decade of life in our 
study population. This pattern is not in conformity 
with the works of Azlan and co-workers who found 
that the most common age group affected in their 
23work was the middle age patients . Furthermore, 
nodal cancer spread appears to favor involvement 
of the right side of the neck in 50% of the patients in 
our series. This observation may just be a chance 
finding. The most affected cervical nodal levels in 
our work were levels IIB, III and IV. 
Nasopharyngeal carcinoma was the commonest 
cancer type responsible for level II, III and IV 
metastasis. These findings are in conformity with 
other reports in the literature linking metastasis to 
cervical nodal level I to III and primary SCC located 
18, 25, 26in mucosa of the upper aerodigestive tract . 
 Prior to pan-endoscopy and biopsy for the elusive 
primary tumor site, patients in the study underwent 
FNAC of neck nodes and CT scan of the neck. A 
positive FNAC result re-enforced the suspicion of 
malignancy in 14 cases and was the last resort as the 
only diagnostic investigation in the two cases of 
thyroid malignancies. Thirteen cases that had 
suspicious areas on the mucosa at upper 
aerodigestive tract pan-endoscopy were solitary 
cervical lymph node excisional biopsy were 
avoided. In these group  of patients, the suspicious 
areas of the nasopharynx was randomly curetted 
using adenoid curette, the suspicious areas of the 
hypopharynx was blindly biopsied using cupped 
biting biopsy forceps while bilaterally biopsy 
tonsillectomy was done in I6 patients except the 2 
cases with metastatic malignant thyroid diseases 
identified from FNAC of cervical lymph nodes.
The remaining 5 patients in our study population, 
solitary cervical lymph node excisional biopsy 
became necessary when macroscopically suspicious 
areas were not visualized during fiber-optic 
laryngoscopy, nasopharyngoscopy or rigid 
hypopharyngoscopy. Although, a direct effect of a 
neck node biopsy on tumor recurrence has not been 
demonstrated, incisional biopsy is strongly 
discouraged due to the risk of further dissemination 
or seeding of tumor and the adverse effect on 
27subsequent surgery of the neck by scar formation .
Out of the 16 randomly performed bilateral 
tonsillectomies in the 16 patients, only 2 patients had 
a report of malignancy in their tonsillar specimens. 
Generally, the histologic yield of pan-endoscopic 
biopsy in our study was 72.2%. This finding in our 
work is higher than the biopsy yield recorded in the 
28, 29works of Acquarelli et al and Coker et al  but lower 
than the findings of Azlan and co-workers who had a 
biopsy yield of 90%. Didolker and colleagues 
reported that in patients with primary lesions, which 
have escaped detection by a staging workup, the 
unknown primary tumor site may be identified in 
2430% to 82% of the cases at autopsy .
Fluoro-2-deoxy-D-glucose positron emission 
tomography (FDG PET) scan was a useful 
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investigation in the workup of patients with 
metastatic cancers with unknown primary site. 
Studies from literatures suggest that biopsies 
carried out after FDG PET can improve the number 
of occult primary detected compared with 
endoscopic examination with speculative 
30, 32
biopsies . The lack of FDP-PET CT in our center 
was a setback that would have increased the 
diagnostic yield of investigations for unknown 
primary tumor site.
CONCLUSION
Metastasis to cervical lymph nodes with unknown 
primary tumor site is not uncommon. Due to 
limited facility for proper investigation in 
developing countries of the West African sub-
region, the search for the definitive anatomic site of 
origin of head and neck malignancy is still a 
daunting task in many facilities. The dearth of 
investigative tools such as FDG PET scan and 
immunohistochemical stains may have diminished 
the yield of random pan endoscopy biopsies in our 
study. Irrespective of the age of the study 
population, nasopharyngeal squamous cell 
carcinoma was most common cause of cervical 
nodal metastasis with unknown primary site.
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